2m 2m 2m 2m 2m 2m 2m
APOGEE THERAP (APGE)
NASDAQ
$134.83+$0.07 (+0.06%)
Price as of Aug 21, 2026 7:30 PM EDT- $8.4BMarket Cap
- 252.10%1-Year Change
- BiotechnologyIndustry
APOGEE THERAP (APGE)
$134.83+$0.07 (+0.06%)
APGE | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $134.75 | ||
Change | $0.00 (0.00%) | ||
Open | $134.79 | ||
High | $134.82 | ||
Low | $134.70 | ||
Previous Close | $134.75 | ||
Volume | 948,283 | ||
30-Day Average Volume | 1,224,211 | ||
1-Week Change | 0.15% | ||
1-Month Change | 0.41% | ||
1-Year Change | 252.10% | ||
3-Year Change | 454.53% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 62.2M | ||
Total Assets | $1.3B | ||
Market Cap | $8.4B | ||
Enterprise Value | $8.3B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$85.9M | ||
Free Cash Flow | -$71.4M | ||
EBIT | -$84.2M | ||
EBITDA | -$83.8M | ||
Net Working Capital | $954.2M | ||
EPS | -$1.14 | ||
Enterprise Value/EBITDA | -99 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 7 | ||
P/E | -118 | ||
PEG | 16 | ||
Price/Free Cash Flow | -117 | ||
Price/Operating Cash Flow | -117 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 50 | ||
Last Split Date | 01/08/2008 | ||
Earnings & Revenue